RL

Richard Lipscombe

Dr Lipscombe has expertise in chemistry, immunology, mass spectrometry, peptide synthesis, high performance computing and robotics. Richard has international experience in both science and business gained over a 30-year period in Australia, USA and the UK, including work in hospital and academic laboratories and commercial organisations.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
06/06/256,854,86010,291,9962,964,865N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
06/06/25
Issued
364,865$0.420$153,243Issue of options
06/06/25
Issued
405,406$0.420$170,270Issue of securities
06/06/25
Issued
324,324$0.420$136,216Issue of securities
21/11/24
Issued
2,600,000$0.169$439,552Issue of options
23/01/24
Sell
2,631,579$0.760$2,000,000Placement